{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:13:24Z","timestamp":1791494004652,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03317-1","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T07:02:02Z","timestamp":1725606122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and safety of first- and second-line antibiotics for cellulitis and erysipelas: a network meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"316","author":[{"given":"Zhou","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"3317_CR1","unstructured":"Michael Y, Shaukat NM (2024) Erysipelas. In: StatPearls edn. Treasure Island (FL) ineligible companies. Disclosure: Nadia Shaukat declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC"},{"issue":"1","key":"3317_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.idc.2020.10.002","volume":"35","author":"RJ Bystritsky","year":"2021","unstructured":"Bystritsky RJ (2021) Cellulitis. Infect Dis Clin N Am 35(1):49\u201360","journal-title":"Infect Dis Clin N Am"},{"key":"3317_CR3","unstructured":"Brown BD, Hood Watson KL (2024) Cellulitis. In: StatPearls edn. Treasure Island (FL) ineligible companies. Disclosure: Kristen Hood Watson declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC"},{"issue":"2","key":"3317_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s40257-021-00659-8","volume":"23","author":"MA Boettler","year":"2022","unstructured":"Boettler MA, Kaffenberger BH, Chung CG (2022) Cellulitis: a review of current practice guidelines and differentiation from Pseudocellulitis. Am J Clin Dermatol 23(2):153\u2013165","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"3317_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jinf.2020.07.030","volume":"81","author":"ELA Cross","year":"2020","unstructured":"Cross ELA, Jordan H, Godfrey R, Onakpoya IJ, Shears A, Fidler K, Peto TEA, Walker AS, Llewelyn MJ (2020) Route and duration of antibiotic therapy in acute cellulitis: a systematic review and meta-analysis of the effectiveness and harms of antibiotic treatment. J Infect 81(4):521\u2013531","journal-title":"J Infect"},{"issue":"8","key":"3317_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/jhm.2593","volume":"11","author":"CG Gunderson","year":"2016","unstructured":"Gunderson CG (2016) Overtreatment of nonpurulent cellulitis. J Hosp Med 11(8):587\u2013590","journal-title":"J Hosp Med"},{"issue":"1","key":"3317_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jemermed.2021.09.015","volume":"62","author":"B Long","year":"2022","unstructured":"Long B, Gottlieb M (2022) Diagnosis and management of Cellulitis and Abscess in the Emergency Department setting: an evidence-based review. J Emerg Med 62(1):16\u201327","journal-title":"J Emerg Med"},{"issue":"5","key":"3317_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s15010-016-0895-x","volume":"44","author":"A Ferreira","year":"2016","unstructured":"Ferreira A, Bolland MJ, Thomas MG (2016) Meta-analysis of randomised trials comparing a penicillin or cephalosporin with a macrolide or lincosamide in the treatment of cellulitis or erysipelas. Infection 44(5):607\u2013615","journal-title":"Infection"},{"issue":"20","key":"3317_CR9","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1001\/jama.2017.5653","volume":"317","author":"GJ Moran","year":"2017","unstructured":"Moran GJ, Krishnadasan A, Mower WR, Abrahamian FM, LoVecchio F, Steele MT, Rothman RE, Karras DJ, Hoagland R, Pettibone S et al (2017) Effect of Cephalexin Plus Trimethoprim-Sulfamethoxazole vs Cephalexin alone on clinical cure of uncomplicated cellulitis: a Randomized Clinical Trial. JAMA 317(20):2088\u20132096","journal-title":"JAMA"},{"key":"3317_CR10","doi-asserted-by":"publisher","first-page":"302","DOI":"10.17161\/kjm.vol15.17931","volume":"15","author":"E Weesner","year":"2022","unstructured":"Weesner E, Ghassemi H, Salapenka I, Konakanchi JS, Maggio G, Sethi R (2022) Injection site reaction to extended-release buprenorphine (Sublocade(\u00ae)) for opioid use disorder fourteen days after Administration. Kans J Med 15:302\u2013304","journal-title":"Kans J Med"},{"issue":"12","key":"3317_CR11","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/cid\/cit122","volume":"56","author":"DJ Pallin","year":"2013","unstructured":"Pallin DJ, Binder WD, Allen MB, Lederman M, Parmar S, Filbin MR, Hooper DC, Camargo CA Jr. (2013) Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial. Clin Infect Diseases: Official Publication Infect Dis Soc Am 56(12):1754\u20131762","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"1","key":"3317_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s43678-022-00433-7","volume":"25","author":"K Yadav","year":"2023","unstructured":"Yadav K, Eagles D, Perry JJ, Taljaard M, Sandino-Gold G, Nemnom MJ, Corrales-Medina V, Suh KN, Stiell IG (2023) High-dose cephalexin for cellulitis: a pilot randomized controlled trial. Cjem 25(1):22\u201330","journal-title":"Cjem"},{"issue":"7","key":"3317_CR13","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097","journal-title":"PLoS Med"},{"issue":"11","key":"3317_CR14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP et al (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777\u2013784","journal-title":"Ann Intern Med"},{"issue":"3","key":"3317_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000051263","volume":"12","author":"M Oremus","year":"2001","unstructured":"Oremus M, Wolfson C, Perrault A, Demers L, Momoli F, Moride Y (2001) Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer\u2019s disease drug trials. Dement Geriatr Cogn Disord 12(3):232\u2013236","journal-title":"Dement Geriatr Cogn Disord"},{"key":"3317_CR16","first-page":"g5630","volume":"349","author":"MA Puhan","year":"2014","unstructured":"Puhan MA, Sch\u00fcnemann HJ, Murad MH, Li T, Brignardello-Petersen R, Singh JA, Kessels AG, Guyatt GH (2014) A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ (Clinical Res ed) 349:g5630","journal-title":"BMJ (Clinical Res ed)"},{"issue":"9","key":"3317_CR17","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1001\/jamaoncol.2015.3062","volume":"1","author":"T Fujii","year":"2015","unstructured":"Fujii T, Le Du F, Xiao L, Kogawa T, Barcenas CH, Alvarez RH, Valero V, Shen Y, Ueno NT (2015) Effectiveness of an adjuvant chemotherapy regimen for early-stage breast Cancer: a systematic review and network Meta-analysis. JAMA Oncol 1(9):1311\u20131318","journal-title":"JAMA Oncol"},{"issue":"7\u20138","key":"3317_CR18","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/sim.3767","volume":"29","author":"S Dias","year":"2010","unstructured":"Dias S, Welton NJ, Caldwell DM, Ades AE (2010) Checking consistency in mixed treatment comparison meta-analysis. Stat Med 29(7\u20138):932\u2013944","journal-title":"Stat Med"},{"issue":"5","key":"3317_CR19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/0272989X12455847","volume":"33","author":"S Dias","year":"2013","unstructured":"Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE (2013) Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med Decis Making: Int J Soc Med Decis Mak 33(5):641\u2013656","journal-title":"Med Decis Making: Int J Soc Med Decis Mak"},{"issue":"2","key":"3317_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1365-2133.1992.tb08048.x","volume":"127","author":"P Bernard","year":"1992","unstructured":"Bernard P, Plantin P, Roger H, Sassolas B, Villaret E, Legrain V, Roujeau JC, Rezvani Y, Scheimberg A (1992) Roxithromycin versus penicillin in the treatment of erysipelas in adults: a comparative study. Br J Dermatol 127(2):155\u2013159","journal-title":"Br J Dermatol"},{"issue":"7369","key":"3317_CR21","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1136\/bmj.325.7369.864","volume":"325","author":"P Bernard","year":"2002","unstructured":"Bernard P, Chosidow O, Vaillant L (2002) Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial. BMJ (Clinical Res ed) 325(7369):864","journal-title":"BMJ (Clinical Res ed)"},{"issue":"6","key":"3317_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/030006059101900602","volume":"19","author":"R Daniel","year":"1991","unstructured":"Daniel R (1991) Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European azithromycin Study Group. J Int Med Res 19(6):433\u2013445","journal-title":"J Int Med Res"},{"issue":"8","key":"3317_CR23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1586\/14787210.2013.816470","volume":"11","author":"ME Griffith","year":"2013","unstructured":"Griffith ME, Ellis MW (2013) Antimicrobial activity against CA-MRSA and treatment of uncomplicated nonpurulent cellulitis. Expert Rev anti-infective Therapy 11(8):777\u2013780","journal-title":"Expert Rev anti-infective Therapy"},{"issue":"5","key":"3317_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S1473-3099(18)30729-1","volume":"19","author":"LF Ibrahim","year":"2019","unstructured":"Ibrahim LF, Hopper SM, Orsini F, Daley AJ, Babl FE, Bryant PA (2019) Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial. Lancet Infect Dis 19(5):477\u2013486","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"3317_CR25","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/BF01975848","volume":"10","author":"R Kiani","year":"1991","unstructured":"Kiani R (1991) Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections. Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol 10(10):880\u2013884","journal-title":"Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol"},{"issue":"Suppl C","key":"3317_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/jac\/37.suppl_C.125","volume":"37","author":"L Montero","year":"1996","unstructured":"Montero L (1996) A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and\/or soft tissue infections. J Antimicrob Chemother 37(Suppl C):125\u2013131","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"3317_CR27","first-page":"1","volume":"22","author":"MGJIDCP Thomas","year":"2014","unstructured":"Thomas MGJIDCP (2014) Oral clindamycin compared with sequential intravenous and oral Flucloxacillin in the treatment of Cellulitis in adults: a Randomized. Double-Blind Trial 22(6):1","journal-title":"Double-Blind Trial"},{"issue":"8","key":"3317_CR28","doi-asserted-by":"publisher","first-page":"Jc40","DOI":"10.7326\/ACPJC-2017-167-8-040","volume":"167","author":"FA Zar","year":"2017","unstructured":"Zar FA (2017) Adding trimethoprim-sulfamethoxazole to cephalexin did not increase clinical cure in uncomplicated cellulitis. Ann Intern Med 167(8):Jc40","journal-title":"Ann Intern Med"},{"key":"3317_CR29","doi-asserted-by":"crossref","unstructured":"Jeong SH, Jang JH, Cho HY, Lee YB (2021) Population Pharmacokinetic Analysis of Cefaclor in healthy Korean subjects. Pharmaceutics 13(5)","DOI":"10.3390\/pharmaceutics13050754"},{"issue":"3","key":"3317_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/antibiotics11030375","volume":"11","author":"YS Alsowaida","year":"2022","unstructured":"Alsowaida YS, Benitez G, Bin Saleh K, Almangour TA, Shehadeh F, Mylonakis E (2022) Effectiveness and safety of Ceftriaxone compared to Standard of Care for Treatment of Bloodstream Infections due to Methicillin-Susceptible Staphylococcus aureus: a systematic review and Meta-analysis. Antibiotics 11(3):375","journal-title":"Antibiotics"},{"issue":"10","key":"3317_CR31","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S1473-3099(19)30288-9","volume":"19","author":"LF Ibrahim","year":"2019","unstructured":"Ibrahim LF, Huang L, Hopper SM, Dalziel K, Babl FE, Bryant PA (2019) Intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis: a cost-effectiveness analysis. Lancet Infect Dis 19(10):1101\u20131108","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"3317_CR32","first-page":"16","volume":"123","author":"P Bernard","year":"1996","unstructured":"Bernard P, Risse L, Bonnetblanc JM (1996) [Pristinamycin in the treatment of acute bacterial dermohypodermitis in adults. An open study of 42 patients]. Ann Dermatol Venereol 123(1):16\u201320","journal-title":"Ann Dermatol Venereol"},{"issue":"13","key":"3317_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7748\/ns.17.13.10.s26","volume":"17","author":"Oral alternative to","year":"2002","unstructured":"Oral alternative to (2002) Penicillin for adult erysipelas. Nurs Stand 17(13):10","journal-title":"Nurs Stand"},{"issue":"4","key":"3317_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.annder.2014.01.001","volume":"141","author":"JL Schmutz","year":"2014","unstructured":"Schmutz JL, Trechot P (2014) [Skin rash mimicking pityriasis rosea Gibert secondary to pristinamycin therapy]. Ann Dermatol Venereol 141(4):325\u2013326","journal-title":"Ann Dermatol Venereol"},{"issue":"1","key":"3317_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jdcr.2015.11.011","volume":"2","author":"F Delcroix","year":"2016","unstructured":"Delcroix F, Arnault JP, Chaby G, Gras-Champel V, Lok C (2016) A predominantly left-sided skin reaction to pristinamycin in a patient with right hemiplegia. JAAD case Rep 2(1):84\u201386","journal-title":"JAAD case Rep"},{"issue":"4","key":"3317_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/pch\/pxac031","volume":"27","author":"ED Trottier","year":"2022","unstructured":"Trottier ED, Farley St-Amand B, Vincent M, Chevalier I, Autmizguine J, Tremblay S, Gouin S (2022) Outpatient management of moderate cellulitis in children using high-dose oral cephalexin. Paediatr Child Health 27(4):213\u2013219","journal-title":"Paediatr Child Health"},{"issue":"2","key":"3317_CR37","doi-asserted-by":"publisher","first-page":"e82694","DOI":"10.1371\/journal.pone.0082694","volume":"9","author":"JM Mason","year":"2014","unstructured":"Mason JM, Thomas KS, Crook AM, Foster KA, Chalmers JR, Nunn AJ, Williams HC (2014) Prophylactic antibiotics to prevent cellulitis of the leg: economic analysis of the PATCH I & II trials. PLoS ONE 9(2):e82694","journal-title":"PLoS ONE"},{"issue":"5","key":"3317_CR38","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cmi.2019.09.019","volume":"26","author":"DR Cranendonk","year":"2020","unstructured":"Cranendonk DR, Opmeer BC, van Agtmael MA, Branger J, Brinkman K, Hoepelman AIM, Lauw FN, Oosterheert JJ, Pijlman AH, Sankatsing SUC et al (2020) Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial. Clin Microbiol Infect 26(5):606\u2013612","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"3317_CR39","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s15010-022-01842-7","volume":"50","author":"K Yadav","year":"2022","unstructured":"Yadav K, Krzyzaniak N, Alexander C, Scott AM, Clark J, Glasziou P, Keijzers G (2022) The impact of antibiotics on clinical response over time in uncomplicated cellulitis: a systematic review and meta-analysis. Infection 50(4):859\u2013871","journal-title":"Infection"},{"issue":"1","key":"3317_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/ced.14398","volume":"46","author":"K Mistry","year":"2021","unstructured":"Mistry K, Sharma S, Patel M, Grindlay D, Janjuha R, Smart P, Levell NJ (2021) Clinical response to antibiotic regimens in lower limb cellulitis: a systematic review. Clin Exp Dermatol 46(1):42\u201349","journal-title":"Clin Exp Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03317-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03317-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03317-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T16:10:32Z","timestamp":1729699832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03317-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["3317"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03317-1","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"30 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, because PubMed, Embase, Cochrane Library, and Web of Science databases belong to public databases, the patients involved in the database have obtained ethical approval, users can download relevant data for free for research and publish relevant articles, and our study is based on open-source data, and the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology do not require research using publicly available data to be submitted for review to their ethics committee, so there are no ethical issues and other conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"603"}}